Search
Hepatitis B Clinical Trials
A listing of 13 Hepatitis B clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 13 of 13
There are currently 13 active clinical trials seeking participants for Hepatitis B research studies. The states with the highest number of trials for Hepatitis B participants are California, New York, Beijing and Baden-Wuerttemberg.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
COVID-19 Vaccine Clinical Trial (Compensation Provided)
Recruiting
Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.
Qualified participants may receive compensation for time and travel.
Qualified participants may receive compensation for time and travel.
Conditions:
Healthy
Vaccine
COVID19
COVID-19
COVID-19 Vaccine
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Vaccine (65+) Clinical Study
Recruiting
We are seeking healthy participants aged 65 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (65+)
Healthy
Older Adults
Seniors
Healthy Volunteers
Liver Cancer Disparities in American Indian and Alaska Native Persons
Recruiting
We are performing a pilot and feasibility randomized controlled trial (RCT) of HCC screening by US + AFP every 6 months (n=100), the current standard-of-care, versus aMRI + AFP every 6 months (n=100) for 12 months (i.e. at time 0, 6 and 12 months) among AI/AN patients with cirrhosis or HBV.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/03/2024
Locations: Cherokee Nation Health Service, Tahlequah, Oklahoma
13 - 13 of 13
